IGF1 and Alzheimer disease: Given that the phenotypes of APP/IR‐dKI mice in this study were opposite to those of IGF‐1R knockout mice, the exacerbated effect of insulin resistance on AD pathology could be derived from a molecular downstream of the insulin/IR pathway rather than of the IGF‐1/IGF‐1R pathway.